46:17

What Can We Learn From Melanomas Unrelated to Sun Exposure?

27:55

TIL Therapy for Advanced Melanoma

13:24

Adjuvant Surgery in Melanoma: New Approaches to Upfront Therapy

16:03

The Role of Genetics in Melanoma: A Family Perspective

13:35

Virtual/Augmented Reality for Primary Prevention Education in Adolescents

11:08

Realities of Artificial Intelligence for Early Melanoma Detection

18:41

Wipe out Melanoma – California: Community Engagement Efforts to Speed Detection

12:59

Melanoma Patient Resources

17:07

Managing Your Treatment on BRAF/MEK Therapy

16:55

Prevention and Self-Screening, How to Take Charge of Your Care

24:23

Tips on Recovering After Surgery

27:39

What to Expect When You Are on Melanoma Immunotherapy

11:11

Long-Term Survivorship After Stage IV Diagnosis

49:03

NeoAdjuvant & Adjuvant Therapy: Questions Getting Answered

22:18

Clinical Trial Options – New Data, Future Therapies

28:42

Mucosal, Acral, Uveal Futures – Time to Invest!

05:26

Welcome & Introductions

20:14

Melanoma Survivorship Panel : Surviving and Thriving

20:10

Radiation Therapy in Melanoma, Novel Paradigms

22:14

Cellular Therapy: TIL Tomorrow and Further

31:38

Evolution of Immune Intelligent Immunotherapy

01:02:27

ASCO 2024: Advances in Melanoma and Related Cancers

11:07

Patient Experience and Resources at Roswell Park

25:09

Behind the Scenes: The Modern Role of Pathology in Melanoma Care

21:28

Strategies for Screening and Prevention of Melanoma

21:36

The Evolving Role of Surgery in Melanoma Management

24:52

The Melanoma Printer for Patients

32:25

Systemic Therapy for Metastatic Melanoma: State of the Art in 2024

22:04

Mole or Monster: Recognizing Melanoma

07:44

Opening Remarks at UPMC Hillman Cancer Center Symposium

26:47

Can We Predict Who Will Respond to Immunotherapy?

25:36

Pediatric Melanoma: The Time is Now for a Standard Treatment Approach

10:19

Preventing Melanoma: How to Protect Your Skin

24:50

The Impact of Diet & Gut Microbiota in Determining Response & Immune-Related Adverse Events (IRAEs)

20:04

Melanoma Tissue Banking-Samples Are Only Part of the Bank—What About the Data?

08:24

Management of Side Effects for BRAF/MEK Inhibitors for Melanoma

02:34

Do Oncolytic Viruses Work?

00:59

What Types of Cancer Can Be Treated with Oncolytic Virus Therapy?

01:21

Which Oncolytic Viruses are the most useful and are they natural?

01:00

How Do Oncolytic Viruses Kill Cancer Cells?

01:10

What Are the Side Effects of Oncolytic Virus Therapy?

01:56

Are Oncolytic Viruses Dangerous?

01:52

What Oncolytic Viruses Are FDA Approved?

00:42

What is Oncolytic Virus Therapy?

23:08

Future Directions In Immunotherapy

20:06

Preventing Melanoma Recurrence After Surgery

17:50

The Making of Melanoma: What is Melanoma? Who Gets it?

20:41

Through The Lens Of An Ocular Oncologist: What is Ocular Melanoma?

23:11

Surgical Management of Melanoma in 2023

30:14

New Diagnosis of Melanoma –The Patient Perspective

26:49

Toxicities Associated with Melanoma Therapies and Treatment: A Closer Look

17:12

Exploring the Impact of Financial Toxicity and Cancer

18:23

Why Is Nutrition Important for Cancer Risk Reduction and Survivorship?

23:18

Overcoming the Fear of Cancer Recurrence

08:40

Are There Resources for Melanoma Patients?

22:36

The Surgical Management of Melanoma: What You Need to Know

19:05

How Does Neoadjuvant Therapy Work?

15:42

Genetics and Melanoma: A Closer Look

21:43

Neoadjuvant Therapy and Adjuvant Therapy for Melanoma

27:33

Advancements in Surgical Techniques for Treating Melanoma